Dimensional Fund Advisors
BOLT icon

Dimensional Fund Advisors’s Bolt Biotherapeutics BOLT Stock Holding History

Dimensional Fund Advisors’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$15K Buy
+504
New +$20.9K ﹤0.01% 3473

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Dimensional Fund Advisors's BOLT Position: Q3 2022 in Review

Dimensional Fund Advisors opened a new position in Bolt Biotherapeutics (BOLT) in Q3 2022: 504 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #3473 among its holdings.

56 funds tracked by Wall St. Rank hold BOLT as of Q3 2022.

  • Dimensional Fund Advisors held 504 shares of Bolt Biotherapeutics worth $15K as of Q3 2022.
  • Bolt Biotherapeutics was a new Dimensional Fund Advisors position in Q3 2022.
  • Bolt Biotherapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3473 holding.
  • 56 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.